Skip to content
My WebMD Sign In, Sign Up

Breast Cancer Health Center

Medical Reference Related to Breast Cancer

  1. Male Breast Cancer Treatment (PDQ®): Treatment - Patient Information [NCI] - Treatment Options for Male Breast Cancer

    Male breast cancer treatment

  2. Breast Cancer Prevention (PDQ®): Prevention - Health Professional Information [NCI] - Overview

    Factors Associated with Increased Risk of Breast Cancer

  3. Male Breast Cancer Treatment (PDQ®): Treatment - Patient Information [NCI] - Treatment Options for Locally Recurrent Male Breast Cancer

    Male breast cancer treatment

  4. Breast Cancer Treatment (PDQ®): Treatment - Health Professional Information [NCI] - General Information About Breast Cancer

    Other PDQ summaries containing information related to breast cancer.

  5. Breast Cancer Treatment and Pregnancy (PDQ®): Treatment - Health Professional Information [NCI] - nci_ncicdr0000062770-nci-header

    This information is produced and provided by the National Cancer Institute (NCI). The information in this topic may have changed since it was written. For the most current information, contact the National Cancer Institute via the Internet web site at http://cancer.gov or call 1-800-4-CANCER.Breast Cancer Treatment and Pregnancy

  6. Breast Cancer Treatment (PDQ®): Treatment - Patient Information [NCI] - Treatment Options by Stage

    Ductal Carcinoma In Situ (DCIS) Treatment of ductal carcinoma in situ (DCIS) may include the following: Breast-conserving surgery with or without radiation therapy or hormone therapy. Total mastectomy with or without hormone therapy. Clinical trials testing breast-conserving surgery and hormone therapy with or without radiation therapy. This summary section refers to specific treatments under .

  7. Breast Cancer Screening (PDQ®): Screening - Health Professional Information [NCI] - Changes to This Summary (04 / 05 / 2013)

    The PDQ cancer information summaries are reviewed regularly and updated as new information becomes available. This section describes the latest changes made to this summary as of the date above.Breast Cancer Screening Modalities—MammographyAdded text about a detailed analysis of Swedish women by county that compared breast cancer mortality in the presence and absence of screening mammography and concluded that screening had little impact on breast cancer mortality (cited Autier et al. as reference 14).Mammography—Variables Associated with AccuracyAdded text to state that the approach of applying both digital and screen-film mammography to individuals in a single arm study may yield a biased estimate of the relative sensitivity of the tests and that an alternative design would randomize individuals to two arms with each test performed in only one arm, comparing the interval cancer rates in the two arms.Harms of Screening MammographyAdded Anxiety as a new subsection.This summary is

  8. Male Breast Cancer Treatment (PDQ®): Treatment - Patient Information [NCI] - Changes to This Summary (12 / 10 / 2012)

    The PDQ cancer information summaries are reviewed regularly and updated as new information becomes available. This section describes the latest changes made to this summary as of the date above.Editorial changes were made to this summary.

  9. Breast Cancer Treatment (PDQ®): Treatment - Health Professional Information [NCI] - Changes to This Summary (04 / 04 / 2013)

    The PDQ cancer information summaries are reviewed regularly and updated as new information becomes available. This section describes the latest changes made to this summary as of the date above. Stage I, II, IIIA, and Operable IIIC Breast CancerAdded Davies et al. as reference 90. Added text to state that it is controversial whether the optimal duration of adjuvant tamoxifen therapy in premenopausal women is 5 years or 10 years.Added text to state that long-term follow-up of the Adjuvant Tamoxifen Longer Against Shorter (ATLAS) trial revealed that 10 years of tamoxifen reduced the risk of breast cancer recurrence, reduced breast cancer mortality, and reduced overall mortality (Level of evidence: 1iiA). Included text to list the risks of tamoxifen therapy after 10 years. Added text to state that the cumulative risk of endometrial cancer during years 5 to 14 from breast cancer diagnosis was 3.1% for women who received 10 years of tamoxifen versus 1.6% for women who received 5 years of

  10. Breast Cancer Screening (PDQ®): Screening - Patient Information [NCI] - Questions or Comments About This Summary

    If you have questions or comments about this summary,please send them to Cancer.gov through the Web site’s Contact Form. We can respond only to email messages written in English. ...

Displaying 41 - 50 of 293 Articles << Prev Page 1 2 3 4 5 6 7 8 9 10 Next >>

Today on WebMD

Breast Cancer Health Check
HEALTH CHECK
breast cancer overview slideshow
SLIDESHOW
 
cancer fighting foods
SLIDESHOW
senior woman
Article
 
Breast Cancer Treatments Improving
VIDEO
Resolved To Quit Smoking
SLIDESHOW
 
Woman getting mammogram
Article
Screening Tests for Women
SLIDESHOW
 
ovarian cancer overview slideshow
SLIDESHOW
serious woman
Article
 
what is your cancer risk
HEALTH CHECK
10 Ways to Revitalize Slideshow
SLIDESHOW